Trials / Completed
CompletedNCT04792736
Prognostic Value of Lactates in ICU
Prognostic Value of Lactates in Predicting Intensive Care Unit Mortality
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 135 (actual)
- Sponsor
- Mongi Slim Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
he aim of this prospective, analytic trial was to evaluate the accuracy of blood lactates levels in predicting mortality in ICU patients.
Detailed description
In this study, conducted over o 12 months period, arterial blood lactates levels were measured in ICU patients at admission (H0), every 6 hours during the first day and and H48. This trial included traumatic, medical and surgical patients requiring ICU stay for a predictive period \> to 24 hours. Blood lactates were evaluated as a prognostic parameter in predicting ICU mortality and compared to classic prognostic scores such as: SOFA score, IGS II and APACHE II. The primary end point was ICU mortality.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood lactate level | Blood lactate level measured at admission H0, every 6 hours during the first 24 h and at H48 |
Timeline
- Start date
- 2019-06-01
- Primary completion
- 2020-06-30
- Completion
- 2020-07-31
- First posted
- 2021-03-11
- Last updated
- 2021-03-11
Locations
2 sites across 1 country: Tunisia
Source: ClinicalTrials.gov record NCT04792736. Inclusion in this directory is not an endorsement.